Seagen (SGEN) Tops Q4 EPS, Revenue
Tweet
Share
E-mail
Get Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Research and development: 92.71M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 92.71M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Seagen (NASDAQ: SGEN) reported Q4 EPS of ($0.50), $0.53 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $528.15 million versus the consensus estimate of $479.84 million.
GUIDANCE:
Seagen sees FY2023 revenue of $2.14-2.24 billion, versus the consensus of $2.3 billion.
For earnings history and earnings-related data on Seagen (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
